Global Tuberculosis (TB) Treatment Market Growth (Status and Outlook) 2025-2031

September 2025 | 99 pages | ID: GF7230BD313CEN
LP Information

Abstracts

According to this study, the global Tuberculosis (TB) Treatment market size will reach US$ million by 2031.

If you have latent tuberculosis, you may need to take only one or two types of TB drug. Active tuberculosis, particularly if it's a drug-resistant strain, will require several drugs at once. The most common medications used to treat tuberculosis include:

Isoniazid

Rifampin (Rifadin, Rimactane)

Ethambutol (Myambutol)

Pyrazinamide

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Tuberculosis (TB) Treatment Industry Forecast” looks at past sales and reviews total world Tuberculosis (TB) Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Tuberculosis (TB) Treatment sales for 2025 through 2031. With Tuberculosis (TB) Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tuberculosis (TB) Treatment industry.

This Insight Report provides a comprehensive analysis of the global Tuberculosis (TB) Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Tuberculosis (TB) Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tuberculosis (TB) Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tuberculosis (TB) Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tuberculosis (TB) Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Tuberculosis (TB) Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Isoniazid
• Rifampin (Rifadin, Rimactane)
• Ethambutol (Myambutol)
• Pyrazinamide

Segmentation by Application:

• Active TB
• Latent TB

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Johnson & Johnson
• Otsuka Pharmaceutical Co., Ltd
• Macleods Pharmaceutical Ltd
• Dong-A ST Co., Ltd
• Lupin Ltd
• Janssen Products, LP
• Mylan
• Sanofi

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Tuberculosis (TB) Treatment Market Size (2020-2031)
  2.1.2 Tuberculosis (TB) Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Tuberculosis (TB) Treatment by Country/Region (2020, 2024 & 2031)
2.2 Tuberculosis (TB) Treatment Segment by Type
  2.2.1 Isoniazid
  2.2.2 Rifampin (Rifadin, Rimactane)
  2.2.3 Ethambutol (Myambutol)
  2.2.4 Pyrazinamide
2.3 Tuberculosis (TB) Treatment Market Size by Type
  2.3.1 Tuberculosis (TB) Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Tuberculosis (TB) Treatment Market Size Market Share by Type (2020-2025)
2.4 Tuberculosis (TB) Treatment Segment by Application
  2.4.1 Active TB
  2.4.2 Latent TB
2.5 Tuberculosis (TB) Treatment Market Size by Application
  2.5.1 Tuberculosis (TB) Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Tuberculosis (TB) Treatment Market Size Market Share by Application (2020-2025)

3 TUBERCULOSIS (TB) TREATMENT MARKET SIZE BY PLAYER

3.1 Tuberculosis (TB) Treatment Market Size Market Share by Player
  3.1.1 Global Tuberculosis (TB) Treatment Revenue by Player (2020-2025)
  3.1.2 Global Tuberculosis (TB) Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Tuberculosis (TB) Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 TUBERCULOSIS (TB) TREATMENT BY REGION

4.1 Tuberculosis (TB) Treatment Market Size by Region (2020-2025)
4.2 Global Tuberculosis (TB) Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Tuberculosis (TB) Treatment Market Size Growth (2020-2025)
4.4 APAC Tuberculosis (TB) Treatment Market Size Growth (2020-2025)
4.5 Europe Tuberculosis (TB) Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Tuberculosis (TB) Treatment Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Tuberculosis (TB) Treatment Market Size by Country (2020-2025)
5.2 Americas Tuberculosis (TB) Treatment Market Size by Type (2020-2025)
5.3 Americas Tuberculosis (TB) Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Tuberculosis (TB) Treatment Market Size by Region (2020-2025)
6.2 APAC Tuberculosis (TB) Treatment Market Size by Type (2020-2025)
6.3 APAC Tuberculosis (TB) Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Tuberculosis (TB) Treatment Market Size by Country (2020-2025)
7.2 Europe Tuberculosis (TB) Treatment Market Size by Type (2020-2025)
7.3 Europe Tuberculosis (TB) Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Tuberculosis (TB) Treatment by Region (2020-2025)
8.2 Middle East & Africa Tuberculosis (TB) Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Tuberculosis (TB) Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL TUBERCULOSIS (TB) TREATMENT MARKET FORECAST

10.1 Global Tuberculosis (TB) Treatment Forecast by Region (2026-2031)
  10.1.1 Global Tuberculosis (TB) Treatment Forecast by Region (2026-2031)
  10.1.2 Americas Tuberculosis (TB) Treatment Forecast
  10.1.3 APAC Tuberculosis (TB) Treatment Forecast
  10.1.4 Europe Tuberculosis (TB) Treatment Forecast
  10.1.5 Middle East & Africa Tuberculosis (TB) Treatment Forecast
10.2 Americas Tuberculosis (TB) Treatment Forecast by Country (2026-2031)
  10.2.1 United States Market Tuberculosis (TB) Treatment Forecast
  10.2.2 Canada Market Tuberculosis (TB) Treatment Forecast
  10.2.3 Mexico Market Tuberculosis (TB) Treatment Forecast
  10.2.4 Brazil Market Tuberculosis (TB) Treatment Forecast
10.3 APAC Tuberculosis (TB) Treatment Forecast by Region (2026-2031)
  10.3.1 China Tuberculosis (TB) Treatment Market Forecast
  10.3.2 Japan Market Tuberculosis (TB) Treatment Forecast
  10.3.3 Korea Market Tuberculosis (TB) Treatment Forecast
  10.3.4 Southeast Asia Market Tuberculosis (TB) Treatment Forecast
  10.3.5 India Market Tuberculosis (TB) Treatment Forecast
  10.3.6 Australia Market Tuberculosis (TB) Treatment Forecast
10.4 Europe Tuberculosis (TB) Treatment Forecast by Country (2026-2031)
  10.4.1 Germany Market Tuberculosis (TB) Treatment Forecast
  10.4.2 France Market Tuberculosis (TB) Treatment Forecast
  10.4.3 UK Market Tuberculosis (TB) Treatment Forecast
  10.4.4 Italy Market Tuberculosis (TB) Treatment Forecast
  10.4.5 Russia Market Tuberculosis (TB) Treatment Forecast
10.5 Middle East & Africa Tuberculosis (TB) Treatment Forecast by Region (2026-2031)
  10.5.1 Egypt Market Tuberculosis (TB) Treatment Forecast
  10.5.2 South Africa Market Tuberculosis (TB) Treatment Forecast
  10.5.3 Israel Market Tuberculosis (TB) Treatment Forecast
  10.5.4 Turkey Market Tuberculosis (TB) Treatment Forecast
10.6 Global Tuberculosis (TB) Treatment Forecast by Type (2026-2031)
10.7 Global Tuberculosis (TB) Treatment Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Tuberculosis (TB) Treatment Forecast

11 KEY PLAYERS ANALYSIS

11.1 Johnson & Johnson
  11.1.1 Johnson & Johnson Company Information
  11.1.2 Johnson & Johnson Tuberculosis (TB) Treatment Product Offered
  11.1.3 Johnson & Johnson Tuberculosis (TB) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Johnson & Johnson Main Business Overview
  11.1.5 Johnson & Johnson Latest Developments
11.2 Otsuka Pharmaceutical Co., Ltd
  11.2.1 Otsuka Pharmaceutical Co., Ltd Company Information
  11.2.2 Otsuka Pharmaceutical Co., Ltd Tuberculosis (TB) Treatment Product Offered
  11.2.3 Otsuka Pharmaceutical Co., Ltd Tuberculosis (TB) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Otsuka Pharmaceutical Co., Ltd Main Business Overview
  11.2.5 Otsuka Pharmaceutical Co., Ltd Latest Developments
11.3 Macleods Pharmaceutical Ltd
  11.3.1 Macleods Pharmaceutical Ltd Company Information
  11.3.2 Macleods Pharmaceutical Ltd Tuberculosis (TB) Treatment Product Offered
  11.3.3 Macleods Pharmaceutical Ltd Tuberculosis (TB) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Macleods Pharmaceutical Ltd Main Business Overview
  11.3.5 Macleods Pharmaceutical Ltd Latest Developments
11.4 Dong-A ST Co., Ltd
  11.4.1 Dong-A ST Co., Ltd Company Information
  11.4.2 Dong-A ST Co., Ltd Tuberculosis (TB) Treatment Product Offered
  11.4.3 Dong-A ST Co., Ltd Tuberculosis (TB) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Dong-A ST Co., Ltd Main Business Overview
  11.4.5 Dong-A ST Co., Ltd Latest Developments
11.5 Lupin Ltd
  11.5.1 Lupin Ltd Company Information
  11.5.2 Lupin Ltd Tuberculosis (TB) Treatment Product Offered
  11.5.3 Lupin Ltd Tuberculosis (TB) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Lupin Ltd Main Business Overview
  11.5.5 Lupin Ltd Latest Developments
11.6 Janssen Products, LP
  11.6.1 Janssen Products, LP Company Information
  11.6.2 Janssen Products, LP Tuberculosis (TB) Treatment Product Offered
  11.6.3 Janssen Products, LP Tuberculosis (TB) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Janssen Products, LP Main Business Overview
  11.6.5 Janssen Products, LP Latest Developments
11.7 Mylan
  11.7.1 Mylan Company Information
  11.7.2 Mylan Tuberculosis (TB) Treatment Product Offered
  11.7.3 Mylan Tuberculosis (TB) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Mylan Main Business Overview
  11.7.5 Mylan Latest Developments
11.8 Sanofi
  11.8.1 Sanofi Company Information
  11.8.2 Sanofi Tuberculosis (TB) Treatment Product Offered
  11.8.3 Sanofi Tuberculosis (TB) Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Sanofi Main Business Overview
  11.8.5 Sanofi Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Tuberculosis (TB) Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Tuberculosis (TB) Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Isoniazid
Table 4. Major Players of Rifampin (Rifadin, Rimactane)
Table 5. Major Players of Ethambutol (Myambutol)
Table 6. Major Players of Pyrazinamide
Table 7. Tuberculosis (TB) Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Tuberculosis (TB) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Tuberculosis (TB) Treatment Market Size Market Share by Type (2020-2025)
Table 10. Tuberculosis (TB) Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Tuberculosis (TB) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Tuberculosis (TB) Treatment Market Size Market Share by Application (2020-2025)
Table 13. Global Tuberculosis (TB) Treatment Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Tuberculosis (TB) Treatment Revenue Market Share by Player (2020-2025)
Table 15. Tuberculosis (TB) Treatment Key Players Head office and Products Offered
Table 16. Tuberculosis (TB) Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Tuberculosis (TB) Treatment Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Tuberculosis (TB) Treatment Market Size Market Share by Region (2020-2025)
Table 21. Global Tuberculosis (TB) Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Tuberculosis (TB) Treatment Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Tuberculosis (TB) Treatment Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Tuberculosis (TB) Treatment Market Size Market Share by Country (2020-2025)
Table 25. Americas Tuberculosis (TB) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Tuberculosis (TB) Treatment Market Size Market Share by Type (2020-2025)
Table 27. Americas Tuberculosis (TB) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Tuberculosis (TB) Treatment Market Size Market Share by Application (2020-2025)
Table 29. APAC Tuberculosis (TB) Treatment Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Tuberculosis (TB) Treatment Market Size Market Share by Region (2020-2025)
Table 31. APAC Tuberculosis (TB) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Tuberculosis (TB) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Tuberculosis (TB) Treatment Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Tuberculosis (TB) Treatment Market Size Market Share by Country (2020-2025)
Table 35. Europe Tuberculosis (TB) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Tuberculosis (TB) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Tuberculosis (TB) Treatment Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Tuberculosis (TB) Treatment Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Tuberculosis (TB) Treatment Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Tuberculosis (TB) Treatment
Table 41. Key Market Challenges & Risks of Tuberculosis (TB) Treatment
Table 42. Key Industry Trends of Tuberculosis (TB) Treatment
Table 43. Global Tuberculosis (TB) Treatment Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Tuberculosis (TB) Treatment Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Tuberculosis (TB) Treatment Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Tuberculosis (TB) Treatment Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Johnson & Johnson Details, Company Type, Tuberculosis (TB) Treatment Area Served and Its Competitors
Table 48. Johnson & Johnson Tuberculosis (TB) Treatment Product Offered
Table 49. Johnson & Johnson Tuberculosis (TB) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Johnson & Johnson Main Business
Table 51. Johnson & Johnson Latest Developments
Table 52. Otsuka Pharmaceutical Co., Ltd Details, Company Type, Tuberculosis (TB) Treatment Area Served and Its Competitors
Table 53. Otsuka Pharmaceutical Co., Ltd Tuberculosis (TB) Treatment Product Offered
Table 54. Otsuka Pharmaceutical Co., Ltd Tuberculosis (TB) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Otsuka Pharmaceutical Co., Ltd Main Business
Table 56. Otsuka Pharmaceutical Co., Ltd Latest Developments
Table 57. Macleods Pharmaceutical Ltd Details, Company Type, Tuberculosis (TB) Treatment Area Served and Its Competitors
Table 58. Macleods Pharmaceutical Ltd Tuberculosis (TB) Treatment Product Offered
Table 59. Macleods Pharmaceutical Ltd Tuberculosis (TB) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Macleods Pharmaceutical Ltd Main Business
Table 61. Macleods Pharmaceutical Ltd Latest Developments
Table 62. Dong-A ST Co., Ltd Details, Company Type, Tuberculosis (TB) Treatment Area Served and Its Competitors
Table 63. Dong-A ST Co., Ltd Tuberculosis (TB) Treatment Product Offered
Table 64. Dong-A ST Co., Ltd Tuberculosis (TB) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Dong-A ST Co., Ltd Main Business
Table 66. Dong-A ST Co., Ltd Latest Developments
Table 67. Lupin Ltd Details, Company Type, Tuberculosis (TB) Treatment Area Served and Its Competitors
Table 68. Lupin Ltd Tuberculosis (TB) Treatment Product Offered
Table 69. Lupin Ltd Tuberculosis (TB) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Lupin Ltd Main Business
Table 71. Lupin Ltd Latest Developments
Table 72. Janssen Products, LP Details, Company Type, Tuberculosis (TB) Treatment Area Served and Its Competitors
Table 73. Janssen Products, LP Tuberculosis (TB) Treatment Product Offered
Table 74. Janssen Products, LP Tuberculosis (TB) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Janssen Products, LP Main Business
Table 76. Janssen Products, LP Latest Developments
Table 77. Mylan Details, Company Type, Tuberculosis (TB) Treatment Area Served and Its Competitors
Table 78. Mylan Tuberculosis (TB) Treatment Product Offered
Table 79. Mylan Tuberculosis (TB) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Mylan Main Business
Table 81. Mylan Latest Developments
Table 82. Sanofi Details, Company Type, Tuberculosis (TB) Treatment Area Served and Its Competitors
Table 83. Sanofi Tuberculosis (TB) Treatment Product Offered
Table 84. Sanofi Tuberculosis (TB) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. Sanofi Main Business
Table 86. Sanofi Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Tuberculosis (TB) Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Tuberculosis (TB) Treatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Tuberculosis (TB) Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Tuberculosis (TB) Treatment Sales Market Share by Country/Region (2024)
Figure 8. Tuberculosis (TB) Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Tuberculosis (TB) Treatment Market Size Market Share by Type in 2024
Figure 10. Tuberculosis (TB) Treatment in Active TB
Figure 11. Global Tuberculosis (TB) Treatment Market: Active TB (2020-2025) & ($ millions)
Figure 12. Tuberculosis (TB) Treatment in Latent TB
Figure 13. Global Tuberculosis (TB) Treatment Market: Latent TB (2020-2025) & ($ millions)
Figure 14. Global Tuberculosis (TB) Treatment Market Size Market Share by Application in 2024
Figure 15. Global Tuberculosis (TB) Treatment Revenue Market Share by Player in 2024
Figure 16. Global Tuberculosis (TB) Treatment Market Size Market Share by Region (2020-2025)
Figure 17. Americas Tuberculosis (TB) Treatment Market Size 2020-2025 ($ millions)
Figure 18. APAC Tuberculosis (TB) Treatment Market Size 2020-2025 ($ millions)
Figure 19. Europe Tuberculosis (TB) Treatment Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Tuberculosis (TB) Treatment Market Size 2020-2025 ($ millions)
Figure 21. Americas Tuberculosis (TB) Treatment Value Market Share by Country in 2024
Figure 22. United States Tuberculosis (TB) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Tuberculosis (TB) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Tuberculosis (TB) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Tuberculosis (TB) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Tuberculosis (TB) Treatment Market Size Market Share by Region in 2024
Figure 27. APAC Tuberculosis (TB) Treatment Market Size Market Share by Type (2020-2025)
Figure 28. APAC Tuberculosis (TB) Treatment Market Size Market Share by Application (2020-2025)
Figure 29. China Tuberculosis (TB) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Tuberculosis (TB) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Tuberculosis (TB) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Tuberculosis (TB) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 33. India Tuberculosis (TB) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Tuberculosis (TB) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Tuberculosis (TB) Treatment Market Size Market Share by Country in 2024
Figure 36. Europe Tuberculosis (TB) Treatment Market Size Market Share by Type (2020-2025)
Figure 37. Europe Tuberculosis (TB) Treatment Market Size Market Share by Application (2020-2025)
Figure 38. Germany Tuberculosis (TB) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 39. France Tuberculosis (TB) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Tuberculosis (TB) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Tuberculosis (TB) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Tuberculosis (TB) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Tuberculosis (TB) Treatment Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Tuberculosis (TB) Treatment Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Tuberculosis (TB) Treatment Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Tuberculosis (TB) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Tuberculosis (TB) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Tuberculosis (TB) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Tuberculosis (TB) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Tuberculosis (TB) Treatment Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Tuberculosis (TB) Treatment Market Size 2026-2031 ($ millions)
Figure 52. APAC Tuberculosis (TB) Treatment Market Size 2026-2031 ($ millions)
Figure 53. Europe Tuberculosis (TB) Treatment Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Tuberculosis (TB) Treatment Market Size 2026-2031 ($ millions)
Figure 55. United States Tuberculosis (TB) Treatment Market Size 2026-2031 ($ millions)
Figure 56. Canada Tuberculosis (TB) Treatment Market Size 2026-2031 ($ millions)
Figure 57. Mexico Tuberculosis (TB) Treatment Market Size 2026-2031 ($ millions)
Figure 58. Brazil Tuberculosis (TB) Treatment Market Size 2026-2031 ($ millions)
Figure 59. China Tuberculosis (TB) Treatment Market Size 2026-2031 ($ millions)
Figure 60. Japan Tuberculosis (TB) Treatment Market Size 2026-2031 ($ millions)
Figure 61. Korea Tuberculosis (TB) Treatment Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Tuberculosis (TB) Treatment Market Size 2026-2031 ($ millions)
Figure 63. India Tuberculosis (TB) Treatment Market Size 2026-2031 ($ millions)
Figure 64. Australia Tuberculosis (TB) Treatment Market Size 2026-2031 ($ millions)
Figure 65. Germany Tuberculosis (TB) Treatment Market Size 2026-2031 ($ millions)
Figure 66. France Tuberculosis (TB) Treatment Market Size 2026-2031 ($ millions)
Figure 67. UK Tuberculosis (TB) Treatment Market Size 2026-2031 ($ millions)
Figure 68. Italy Tuberculosis (TB) Treatment Market Size 2026-2031 ($ millions)
Figure 69. Russia Tuberculosis (TB) Treatment Market Size 2026-2031 ($ millions)
Figure 70. Egypt Tuberculosis (TB) Treatment Market Size 2026-2031 ($ millions)
Figure 71. South Africa Tuberculosis (TB) Treatment Market Size 2026-2031 ($ millions)
Figure 72. Israel Tuberculosis (TB) Treatment Market Size 2026-2031 ($ millions)
Figure 73. Turkey Tuberculosis (TB) Treatment Market Size 2026-2031 ($ millions)
Figure 74. Global Tuberculosis (TB) Treatment Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Tuberculosis (TB) Treatment Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Tuberculosis (TB) Treatment Market Size 2026-2031 ($ millions)